Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery

Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery: A Double-Blind Randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07372547

Enrollment

100

Registered

2026-01-28

Start date

2026-01-20

Completion date

2028-01-20

Last updated

2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Post-void Residual Volume, Recatheterization, Urinary Retention, UTI

Brief summary

The goal of this clinical trial is to learn if voiding in a standing position in the shower, rather than sitting on a toilet, may reduce pain associated with the act of voiding, thereby facilitating micturition and decreasing both post-void residual volume and the risk of subsequent urinary retention in women that underwent benign vaginal surgeries.

Interventions

BEHAVIORALVoiding position - Standing in the shower

After the removal of urine catheter, for the first micturation the woman will stand in the shower with the water on her vulvar area

BEHAVIORALVoiding position - Sitting on the toilet

After the removal of urine catheter, for the first micturation the women will sit on the toiled

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Caregiver)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* Adult women (≥18 years old). * Undergoing benign vaginal gynecologic surgery with indwelling catheter during surgery. * No bladder injury during surgery. * Ability and willingness to consent. * No known neurological or urinary conditions affecting voiding. * No active urinary tract infection at time of catheter removal.

Exclusion criteria

* Bladder injury during surgery. * Neurological disease affecting bladder function. * Active urinary tract infection. * Inability to void either standing in shower or sitting (depending on randomization).

Design outcomes

Primary

Measure	Time frame	Description
Post-void residual volume>150 CC	The following 7 days after surgery	after the first void following catheter removal

Secondary

Measure	Time frame	Description
Success rate of voiding trial	The following 7 days after surgery	no need for recatheterization
Pain during micturition	The following 7 days after surgery	Pain during micturition, using The Visual Analogue Scale (VAS) 0-10. O means no pain, 10 means worst pain imaginable.
UTI	The following 7 days after surgery	in the 7 days following the surgery
Urinary retention	The following 7 days after surgery	REST\>150 ml
Post-void residual volume	The following 7 days after surgery	in ml

Countries

Israel

Contacts

CONTACTElad Preuss, M.D

eladp@assuta.co.il+072545228700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026